QQQ   283.85 (+1.18%)
AAPL   143.01 (+1.47%)
MSFT   247.71 (+1.37%)
META   116.13 (+1.93%)
GOOGL   94.26 (-0.72%)
AMZN   89.78 (+1.49%)
TSLA   170.93 (-1.79%)
NVDA   167.92 (+4.17%)
NIO   13.26 (+5.41%)
BABA   93.39 (+5.73%)
AMD   70.68 (+0.77%)
T   19.16 (-0.73%)
MU   55.41 (+2.95%)
CGC   3.18 (-1.85%)
F   13.14 (+0.31%)
GE   83.49 (-1.78%)
DIS   92.79 (+0.69%)
AMC   6.28 (+3.80%)
PYPL   75.18 (+1.02%)
PFE   51.05 (+1.61%)
NFLX   307.34 (-0.35%)
QQQ   283.85 (+1.18%)
AAPL   143.01 (+1.47%)
MSFT   247.71 (+1.37%)
META   116.13 (+1.93%)
GOOGL   94.26 (-0.72%)
AMZN   89.78 (+1.49%)
TSLA   170.93 (-1.79%)
NVDA   167.92 (+4.17%)
NIO   13.26 (+5.41%)
BABA   93.39 (+5.73%)
AMD   70.68 (+0.77%)
T   19.16 (-0.73%)
MU   55.41 (+2.95%)
CGC   3.18 (-1.85%)
F   13.14 (+0.31%)
GE   83.49 (-1.78%)
DIS   92.79 (+0.69%)
AMC   6.28 (+3.80%)
PYPL   75.18 (+1.02%)
PFE   51.05 (+1.61%)
NFLX   307.34 (-0.35%)
QQQ   283.85 (+1.18%)
AAPL   143.01 (+1.47%)
MSFT   247.71 (+1.37%)
META   116.13 (+1.93%)
GOOGL   94.26 (-0.72%)
AMZN   89.78 (+1.49%)
TSLA   170.93 (-1.79%)
NVDA   167.92 (+4.17%)
NIO   13.26 (+5.41%)
BABA   93.39 (+5.73%)
AMD   70.68 (+0.77%)
T   19.16 (-0.73%)
MU   55.41 (+2.95%)
CGC   3.18 (-1.85%)
F   13.14 (+0.31%)
GE   83.49 (-1.78%)
DIS   92.79 (+0.69%)
AMC   6.28 (+3.80%)
PYPL   75.18 (+1.02%)
PFE   51.05 (+1.61%)
NFLX   307.34 (-0.35%)
QQQ   283.85 (+1.18%)
AAPL   143.01 (+1.47%)
MSFT   247.71 (+1.37%)
META   116.13 (+1.93%)
GOOGL   94.26 (-0.72%)
AMZN   89.78 (+1.49%)
TSLA   170.93 (-1.79%)
NVDA   167.92 (+4.17%)
NIO   13.26 (+5.41%)
BABA   93.39 (+5.73%)
AMD   70.68 (+0.77%)
T   19.16 (-0.73%)
MU   55.41 (+2.95%)
CGC   3.18 (-1.85%)
F   13.14 (+0.31%)
GE   83.49 (-1.78%)
DIS   92.79 (+0.69%)
AMC   6.28 (+3.80%)
PYPL   75.18 (+1.02%)
PFE   51.05 (+1.61%)
NFLX   307.34 (-0.35%)
NASDAQ:UTHR

United Therapeutics - UTHR SEC Filings & 10K Form

$279.36
+2.28 (+0.82%)
(As of 12/8/2022 11:47 AM ET)
Add
Compare
Today's Range
$276.97
$281.24
50-Day Range
$205.95
$279.89
52-Week Range
$158.38
$282.22
Volume
2,890 shs
Average Volume
323,283 shs
Market Capitalization
$12.73 billion
P/E Ratio
19.00
Dividend Yield
N/A
Price Target
$282.00

Recent United Therapeutics SEC Filings

DateFilerForm TypeView
12/07/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2022
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2022
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2022
7:09 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2022
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2022
3:37 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2022
3:31 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2022
3:31 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2022
3:31 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
6:03 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2022
5:05 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2022
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2022
5:05 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2022
5:03 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2022
3:33 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2022
6:15 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2022
3:34 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2022
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2022
5:00 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2022
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2022
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2022
3:31 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2022
5:31 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
6:01 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/03/2022
5:06 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2022
5:03 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2022
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4/A
07/11/2022
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4/A
07/11/2022
3:30 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4/A
07/11/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:52 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:51 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:50 PM
Klein Katherine J (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:49 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:48 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:47 PM
MAXWELL LINDA (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:45 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:42 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:41 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
4:40 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
4:08 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2022
3:37 PM
United Therapeutics (Issuer)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2022
3:31 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2022
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
6:01 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
6:00 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
4:37 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
3:46 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2022
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2022
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2022
3:32 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2022
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
5:08 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2022
5:04 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:01 AM
United Therapeutics (Filer)
Form DEFA14A
04/29/2022
5:01 AM
United Therapeutics (Filer)
Form DEF 14A
04/22/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2022
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2022
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2022
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2021
3:31 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2021
5:19 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2021
5:27 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2021
3:33 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
5:01 AM
United Therapeutics (Filer)
Form DEFA14A
08/19/2021
5:00 AM
United Therapeutics (Filer)
Form DEF 14A
08/04/2021
6:31 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/04/2021
5:13 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2021
5:04 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/14/2021
5:15 AM
United Therapeutics (Filer)
Form PRE 14A
07/09/2021
3:51 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:50 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:49 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:49 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
3:32 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
3:39 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:UTHR) was last updated on 12/8/2022 by MarketBeat.com Staff